Perrigo Company plc (PIG.F)
- Previous Close
28.93 - Open
29.07 - Bid 29.93 x 30000
- Ask 30.15 x 30000
- Day's Range
29.07 - 29.07 - 52 Week Range
24.08 - 36.25 - Volume
25 - Avg. Volume
5 - Market Cap (intraday)
4.035B - Beta (5Y Monthly) 0.65
- PE Ratio (TTM)
-- - EPS (TTM)
-0.03 - Earnings Date --
- Forward Dividend & Yield 1.01 (3.47%)
- Ex-Dividend Date Mar 7, 2024
- 1y Target Est
51.00
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
www.perrigo.com9,140
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: PIG.F
Performance Overview: PIG.F
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PIG.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PIG.F
Valuation Measures
Market Cap
4.03B
Enterprise Value
7.13B
Trailing P/E
395.89
Forward P/E
12.18
PEG Ratio (5yr expected)
0.83
Price/Sales (ttm)
0.91
Price/Book (mrq)
0.89
Enterprise Value/Revenue
1.53
Enterprise Value/EBITDA
13.58
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.27%
Return on Assets (ttm)
1.64%
Return on Equity (ttm)
-0.09%
Revenue (ttm)
4.66B
Net Income Avi to Common (ttm)
-4.4M
Diluted EPS (ttm)
-0.03
Balance Sheet and Cash Flow
Total Cash (mrq)
744.4M
Total Debt/Equity (mrq)
89.60%
Levered Free Cash Flow (ttm)
498.94M
Research Analysis: PIG.F
Company Insights: PIG.F
PIG.F does not have Company Insights